Medium Term Survivorship of Cementless THA Performed Using the Bone Preservation Tri-Lock Femoral Stem



Status:Not yet recruiting
Healthy:No
Age Range:21 - Any
Updated:4/2/2016
Contact:Tiffany Morrison, MS, CCRP
Email:tiffany.morrison@rothmaninstitute.com
Phone:267-339-7818

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

This prospective, randomized study will study the 2 year survivorship and short term
outcomes of a currently-used femoral stem: the Bone Preservation Tri-Lock femoral stem using
two surgical approaches. The surgical approaches being studied are direct anterior and
anterolateral. Implant survivorship, radiographic positioning, and functional outcomes will
be compared. Subjects will be randomized to surgical approach and followed for a period of
two years.


Inclusion Criteria:

- Patient signed an IRB, study specific informed patient consent

- Patient is a male or non-pregnant female age 21 years or older at the time of study
device implantation

- Patient has primary diagnosis of non-inflammatory degenerative joint disease.

- Patient is a candidate for primary cementless total hip replacement

- Patient is willing and able to comply with postoperative scheduled clinical and
radiographic evaluations and rehabilitation.

Exclusion Criteria:

- Patient has a Body Mass Index (BMI) > 40 Kg/m2

- Patient has an active or suspected infection at the time of device implantation

- Patient is immunologically suppressed.

- Patient requires revision surgery of a previously implanted total hip replacement

- Patient has a known sensitivity to device materials
We found this trial at
2
sites
Rothman Institute
Egg Harbor Township, New Jersey 08234
?
mi
from
Egg Harbor Township, NJ
Click here to add this to my saved trials
Rothman Institute
Philadelphia, Pennsylvania 19107
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials